Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 9,781–9,800 of 18,020 recalls

FDA Recall Terminated Historical recordClass II

Allergy & Hay Fever Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7011-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Muscle & Joint Pain Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7041-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diarrhea Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7022-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sore Throat & Laryngitis Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7014-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sinus Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7013-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Skin Irritation & Itch Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7002-7

by Beaumont Bio-med, Inc.

Reason
CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532 409 INDIA, NDC 55111-179-15, UPC 35511179153

by Dr. Reddy's Laboratories, Inc.

Reason
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31

by Baxter Healthcare Corporation

Reason
cGMP Deviation
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173, Bloombury, NJ 08804, UPC 70092103417.

by QuVa Pharma, Inc.

Reason
Subpotent Drug: Product may not have the active ingredient present in the bag.
Published
September 26, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.

by ACCORD HEALTHCARE, INC.

Reason
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Respitrol, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-003-02

by Hellolife

Reason
Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Thyroveev, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-025-02

by Hellolife

Reason
Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Neuroveen, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-015-02

by Hellolife

Reason
Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Compulsin, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-034-02

by Hellolife

Reason
Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-05

by Mylan Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01

by Mylan Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

by Par Pharmaceutical, Inc.

Reason
Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01

by Pfizer Inc.

Reason
Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point
Published
September 19, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01

by Akorn, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Published
September 12, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-888-90

by Avkare Incorporated

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 12, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.